Skip to content
Menu

Candel Therapeutics, Inc. CADL

Full chart Compare
Set alert

Price alert · CADL

All alert types
5.32 USD -0.08 (-1.48%)

Regular-session close

5.29 -0.03 -0.48%

After hours · Nov 18, 7:18 PM ET

5.26 Day range 5.64
4.35 52-week range 14.00
YTD
-5.84%
1 year
+15.15%

Revenue & Expenses

Revenue Profit Costs
Other Income$15.88MOther Operating Income$48.00KGross Profit$125.00KNet Loss$18.79MExpenses$34.85MSelling, General & Admin$14.06MResearch & Development$20.79MRevenue$125.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

CADL annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-48.27M-33.37M-38.39M-34.72M-25.73M
-38.18M-55.18M-37.94M-18.79M-36.12M
-0.72-1.74-1.31-0.65-1.91
CADL annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
120.15M102.92M35.68M70.32M83.07M
125.19M106.87M41.20M77.69M89.20M
73.27M40.54M28.46M29.98M25.07M
49.03M13.47M22.76M22.80M560.00K
51.92M66.33M12.74M47.71M64.14M
CADL annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-38.31M-27.02M-34.24M-31.42M-22.22M
-560.00K-16.00K-280.00K-1.30M-1.83M
56.10M94.28M-121.00K19.97M71.80M
-560.00K-16.00K-280.00K-1.30M-1.83M
17.23M67.24M-34.65M-12.74M47.75M